{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:36:46Z","timestamp":1767919006143,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jad-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.jad.2015.05.065","type":"journal-article","created":{"date-parts":[[2015,6,24]],"date-time":"2015-06-24T17:21:08Z","timestamp":1435166468000},"page":"12-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Multiplex immunoassay analysis of plasma shows differences in biomarkers related to manic or mixed mood states in bipolar disorder patients"],"prefix":"10.1016","volume":"185","author":[{"given":"Frieder","family":"Haenisch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murtada","family":"Alsaif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul C.","family":"Guest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Rahmoune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert H.","family":"Yolken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faith","family":"Dickerson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Bahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2015.05.065_bib1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.eurpsy.2008.07.006","article-title":"The primacy of mania: a reconsideration of mood disorders","volume":"24","author":"Koukopoulos","year":"2009","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jad.2015.05.065_bib2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1399-5618.2005.00197.x","article-title":"Pharmacotherapy of bipolar mixed states","volume":"7","author":"Kr\u00fcger","year":"2005","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2015.05.065_bib3","unstructured":"Mathers, C. D., Lopez, A. D.,\u00a0Murray, C. J. L. Global Burden of Disease and Risk Factors. (World Bank, 2006)."},{"key":"10.1016\/j.jad.2015.05.065_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2015.05.065_bib5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nrg2381","article-title":"Psychiatric genetics: progress amid controversy","volume":"9","author":"Burmeister","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jad.2015.05.065_bib6","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1176\/appi.ajp.2014.13081008","article-title":"A critical appraisal of neuroimaging studies of bipolar disorder: toward a new conceptualization of underlying neural circuitry and a road map for future research","volume":"171","author":"Phillips","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2015.05.065_bib7","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jpsychires.2006.07.013","article-title":"Serum S100B and antioxidant enzymes in bipolar patients","volume":"41","author":"Andreazza","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2015.05.065_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0165-0327(00)00252-4","article-title":"Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania","volume":"64","author":"Tsai","year":"2001","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2015.05.065_bib9","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.psyneuen.2006.02.006","article-title":"Altered glucocorticoid receptor signaling cascade in lymphocytes of bipolar disorder patients","volume":"31","author":"Spiliotaki","year":"2006","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jad.2015.05.065_bib10","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1399-5618.2007.00493.x","article-title":"Immune variations in bipolar disorder: phasic differences","volume":"9","author":"Ortiz-Dom\u00ednguez","year":"2007","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2015.05.065_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jad.2013.12.008","article-title":"Multiplex immunoassay analysis of plasma shows prominent upregulation of growth factor activity pathways linked to GSK3\u03b2 signaling in bipolar patients","volume":"156","author":"Haenisch","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2015.05.065_bib12","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/mp.2011.42","article-title":"Identification of a biological signature for schizophrenia in serum","volume":"17","author":"Schwarz","year":"2012","journal-title":"Mol. Psychiatry"},{"issue":"Suppl 2","key":"10.1016\/j.jad.2015.05.065_bib13","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1007\/BF00400826","article-title":"Insulin secretory granule biogenesis and the proinsulin-processing endopeptidases","volume":"37","author":"Hutton","year":"1994","journal-title":"Diabetologia"},{"key":"10.1016\/j.jad.2015.05.065_bib14","doi-asserted-by":"crossref","first-page":"29556","DOI":"10.1074\/jbc.M111.219675","article-title":"Neuronal brain-derived neurotrophic factor is synthesized in excess, with levels regulated by sortilin-mediated trafficking and lysosomal degradation","volume":"286","author":"Evans","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jad.2015.05.065_bib15","first-page":"489","article-title":"Evidence on Pharmacologic Treatments Diagnosis and Treatment of Bipolar Disorders in Adults","author":"Jann","year":"2014","journal-title":"A Review of the"},{"key":"10.1016\/j.jad.2015.05.065_bib16","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ana.410430406","article-title":"Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy","volume":"43","author":"Isoj\u00e4rvi","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jad.2015.05.065_bib17","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/mp.2009.81","article-title":"Increased levels of circulating insulin-related peptides in first-onset, antipsychotic na\u00efve schizophrenia patients","volume":"15","author":"Guest","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2015.05.065_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/archneurol.2010.225","article-title":"Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes","volume":"68","author":"Baker","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jad.2015.05.065_bib19","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1042\/BST0331041","article-title":"Increased risk of Alzheimer\u2019s disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology?","volume":"33","author":"Biessels","year":"2005","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.jad.2015.05.065_bib20","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.neurobiolaging.2009.10.009","article-title":"Efficacy of PPAR-\u03b3 agonist pioglitazone in mild Alzheimer disease","volume":"32","author":"Sato","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jad.2015.05.065_bib21","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.psyneuen.2010.12.018","article-title":"Altered levels of circulating insulin and other neuroendocrine hormones associated with the onset of schizophrenia","volume":"36","author":"Guest","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jad.2015.05.065_bib22","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0002-9378(16)32480-2","article-title":"Metabolic effects of progesterone","volume":"142","author":"Kalkhoff","year":"1982","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jad.2015.05.065_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.pneurobio.2014.08.002","article-title":"Applications of blood-based protein biomarker strategies in the study of psychiatric disorders","volume":"122C","author":"Chan","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jad.2015.05.065_bib24","article-title":"Neuroimmune biomarkers in schizophrenia","author":"Tomasik","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2015.05.065_bib25","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/cne.21543","article-title":"Characterization of brainstem peptide YY (PYY) neurons","volume":"506","author":"Glavas","year":"2008","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.jad.2015.05.065_bib26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jad.2014.08.058","article-title":"Decreased plasma levels of brain-derived neurotrophic factor (BDNF) during mixed episodes of bipolar disorder","volume":"171","author":"Piccinni","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2015.05.065_bib27","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jad.2014.11.044","article-title":"BDNF as a biomarker for successful treatment of mood disorders: a systematic and quantitative meta-analysis","volume":"174C","author":"Polyakova","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2015.05.065_bib28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/prca.201100061","article-title":"Analysis of serum and plasma identifies differences in molecular coverage, measurement variability, and candidate biomarker selection","volume":"6","author":"Alsaif","year":"2012","journal-title":"Proteomics. Clin. Appl."},{"key":"10.1016\/j.jad.2015.05.065_bib29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0165-0327(00)00157-9","article-title":"Inflammatory markers in major depression and melancholia","volume":"63","author":"Rothermundt","year":"2001","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2015.05.065_bib30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jpsychires.2014.04.017","article-title":"Inflammatory mediators of cognitive impairment in bipolar disorder","volume":"56","author":"Bauer","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2015.05.065_bib31","doi-asserted-by":"crossref","first-page":"e91076","DOI":"10.1371\/journal.pone.0091076","article-title":"Putative transcriptomic biomarkers in the inflammatory cytokine pathway differentiate major depressive disorder patients from control subjects and bipolar disorder patients","volume":"9","author":"Powell","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jad.2015.05.065_bib32","doi-asserted-by":"crossref","first-page":"e365","DOI":"10.1038\/tp.2014.8","article-title":"Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder","volume":"4","author":"Fillman","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2015.05.065_bib33","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1517\/13543776.2014.937424","article-title":"Matrix metalloproteinase inhibitors: a patent review (2011\u20132013)","volume":"24","author":"Li","year":"2014","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.jad.2015.05.065_bib34","doi-asserted-by":"crossref","first-page":"e94370","DOI":"10.1371\/journal.pone.0094370","article-title":"Association between serum tissue inhibitor of matrix metalloproteinase-1 levels and mortality in patients with severe brain trauma injury","volume":"9","author":"Lorente","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jad.2015.05.065_bib35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2202-10-17","article-title":"Matrix metalloproteinase-7 facilitates immune access to the CNS in experimental autoimmune encephalomyelitis","volume":"10","author":"Buhler","year":"2009","journal-title":"BMC Neurosci."},{"issue":"Suppl 1","key":"10.1016\/j.jad.2015.05.065_bib36","first-page":"S22","article-title":"[Psychotherapeutic interventions in bipolar disorders\u2013treatment programmes, their contents and effectiveness]","volume":"81","author":"Schaub","year":"2013","journal-title":"Fortschr. Neurol. Psychiatr."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032715003717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032715003717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T09:29:10Z","timestamp":1537522150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032715003717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":36,"alternative-id":["S0165032715003717"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2015.05.065","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiplex immunoassay analysis of plasma shows differences in biomarkers related to manic or mixed mood states in bipolar disorder patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2015.05.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}